Literature DB >> 17208431

Cell cycle kinases in cancer.

Marcos Malumbres1, Mariano Barbacid.   

Abstract

Cell division in mammalian cells is driven by protein kinases that regulate progression through the various phases of the cell cycle. Cyclin-dependent kinases (Cdks) regulate cell cycle commitment, DNA synthesis and the onset of mitosis. Kinases of the Aurora, Polo and Nek families participate in the centrosome cycle and modulate spindle function. Additional kinases such as Bub1, BubR1 and Mps1 regulate the spindle assembly checkpoint. It has been well established that misregulation of Cdks is one of the most frequent alterations in human cancer. Recent evidence indicates that mutations involving mitotic kinases are also linked to tumor development. These findings suggest novel strategies to use cell cycle kinases as targets for therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17208431     DOI: 10.1016/j.gde.2006.12.008

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  130 in total

1.  The kinetochore protein Bub1 participates in the DNA damage response.

Authors:  Chunying Yang; Haibo Wang; Yiran Xu; Kathryn L Brinkman; Hiromichi Ishiyama; Stephen T C Wong; Bo Xu
Journal:  DNA Repair (Amst)       Date:  2011-11-09

2.  Function following form: functional differentiation of mammary epithelial cells requires laminin-induced polarization of PI3-kinase.

Authors:  Derek C Radisky
Journal:  Cell Cycle       Date:  2011-01-01       Impact factor: 4.534

3.  Study on the effect of IRE1a on cell growth and apoptosis via modulation PLK1 in ER stress response.

Authors:  Xiangzhu Li; Huifang Zhu; Huizhe Huang; Rong Jiang; Wenjun Zhao; Yanna Liu; Jinghua Zhou; Feng-Jin Guo
Journal:  Mol Cell Biochem       Date:  2012-06       Impact factor: 3.396

4.  The NIMA-family kinase Nek3 regulates microtubule acetylation in neurons.

Authors:  Jufang Chang; Robert H Baloh; Jeffrey Milbrandt
Journal:  J Cell Sci       Date:  2009-06-09       Impact factor: 5.285

Review 5.  Targeting cancer with small molecule kinase inhibitors.

Authors:  Jianming Zhang; Priscilla L Yang; Nathanael S Gray
Journal:  Nat Rev Cancer       Date:  2009-01       Impact factor: 60.716

Review 6.  Small-molecule inhibitors of the Myc oncoprotein.

Authors:  Steven Fletcher; Edward V Prochownik
Journal:  Biochim Biophys Acta       Date:  2014-03-19

Review 7.  Cell cycle, CDKs and cancer: a changing paradigm.

Authors:  Marcos Malumbres; Mariano Barbacid
Journal:  Nat Rev Cancer       Date:  2009-03       Impact factor: 60.716

8.  Polo-like kinase 1 (Plk1) overexpression enhances ionizing radiation-induced cancer formation in mice.

Authors:  Zhiguo Li; Jinghui Liu; Jie Li; Yifan Kong; George Sandusky; Xi Rao; Yunlong Liu; Jun Wan; Xiaoqi Liu
Journal:  J Biol Chem       Date:  2017-09-12       Impact factor: 5.157

9.  Proteomic analysis of the human cyclin-dependent kinase family reveals a novel CDK5 complex involved in cell growth and migration.

Authors:  Shuangbing Xu; Xu Li; Zihua Gong; Wenqi Wang; Yujing Li; Binoj Chandrasekharan Nair; Hailong Piao; Kunyu Yang; Gang Wu; Junjie Chen
Journal:  Mol Cell Proteomics       Date:  2014-08-05       Impact factor: 5.911

10.  Aurora kinase A (AURKA) and never in mitosis gene A-related kinase 6 (NEK6) genes are upregulated in erosive esophagitis and esophageal adenocarcinoma.

Authors:  Elmas Kasap; Seda Örenay Boyacioglu; Mehmet Korkmaz; Elif Saritas Yuksel; Belkis Unsal; Erkan Kahraman; Omer Ozütemiz; Hakan Yuceyar
Journal:  Exp Ther Med       Date:  2012-04-25       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.